US Broker Ratings

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a Promising 17.99% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the healthcare sector, presents a compelling investment opportunity for those looking to diversify their portfolio with a..

Zimmer Biomet Holdings, Inc. (ZBH) Investor Outlook: Navigating a 4.54% Upside with Healthcare Innovation

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a stalwart in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $21.02..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a Potential 28% Upside for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the global healthcare sector, remains an intriguing option for investors with its strong market presence in..

ResMed Inc. (RMD) Stock Analysis: Evaluating a 6.32% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a leader in the healthcare sector, is renowned for its innovative solutions in medical instruments and supplies, particularly focusing on respiratory disorders...

Medtronic plc (MDT) Investor Outlook: Balancing Dividend Yield with Growth Potential

Medtronic plc (MDT), a stalwart in the medical devices industry, is a compelling investment consideration for those looking to balance consistent dividend yields with growth potential...

McKesson Corporation (MCK) Stock Analysis: Healthcare Titan with 14.84% Potential Upside

For investors eyeing the healthcare sector, McKesson Corporation (NYSE: MCK) presents a formidable opportunity. As a leading player in the medical distribution industry, McKesson operates across..

Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 9.95% Potential Upside Amidst Strong Revenue Growth

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, has captured investor attention with its robust revenue growth and promising market position. Operating..

Amgen Inc. (AMGN) Stock Analysis: A Healthcare Giant with a 99% Return on Equity and 8.4% Upside Potential

Amgen Inc. (NASDAQ: AMGN) remains a formidable presence in the healthcare sector, particularly within the general drug manufacturing industry. With a market capitalization of $154.89 billion,..

AstraZeneca PLC (AZN) Stock Analysis: Exploring an 8.40% Upside Potential

AstraZeneca PLC (AZN), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio and strategic collaborations. Known for its innovation in..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 17% Potential Upside in the Booming Health Information Sector

Veeva Systems Inc. (NYSE: VEEV) stands as a formidable player in the health information services industry, offering innovative cloud-based software solutions tailored to the life sciences..

Novo Nordisk A/S (NVO) Stock Analysis: Is a 13.28% Potential Upside Within Reach?

Novo Nordisk A/S (NYSE: NVO) stands as a titan in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of approximately $248.72..

Vertex Pharmaceuticals (VRTX) Investor Outlook: Navigating a Promising 23% Upside Potential

Vertex Pharmaceuticals Incorporated (VRTX), a prominent player in the biotechnology sector, continues to be a company worth watching for investors seeking growth opportunities. With a market..

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with Robust 3.12% Dividend Yield and Promising Growth Prospects

AbbVie Inc. (NYSE: ABBV), a formidable player in the healthcare sector, continues to captivate investors with its impressive market position and substantial income potential. With a..

Danaher Corporation (DHR) Stock Analysis: A 19.50% Upside Potential Beckons Investors

Danaher Corporation (NYSE: DHR), a leading entity in the diagnostics and research industry, is capturing investor attention with its intriguing growth potential and robust market positioning...

Edwards Lifesciences (EW) Investor Outlook: Analyzing Potential Upside in the Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW), a key player in the healthcare sector specializing in medical devices, offers investors a compelling growth narrative amidst the backdrop of..

Alcon Inc. (ALC) Stock Analysis: Eye-Catching Growth Potential with 22.29% Upside

Alcon Inc. (NYSE: ALC), a stalwart in the healthcare sector, is making waves in the medical instruments and supplies industry with its innovative eye care products...

CVS Health Corporation (CVS) Stock Analysis: Strong Buy Ratings and 11.51% Potential Upside

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, is capturing significant investor attention with its robust market presence and attractive growth prospects. With..

Johnson & Johnson (JNJ) Stock Analysis: Is the Healthcare Giant a Buy with Its Solid Dividend Yield?

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, has long been a favorite among investors for its robust product portfolio and consistent dividend..

Cel-Sci Corporation (CVM) Stock Analysis: A Biotech with Over 3,000% Potential Upside

Cel-Sci Corporation (CVM) presents an intriguing proposition for investors fascinated by the biotechnology sector. With its focus on leveraging the immune system to combat cancer and..

MBX Biosciences, Inc. (MBX) Investor Outlook: Analyst Ratings Suggest 164% Potential Upside

MBX Biosciences, Inc. (NASDAQ: MBX) is capturing investor attention with its promising portfolio of precision peptide therapies and a significant potential upside. With a market capitalization..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds